Corruption and spread of pathogenic proteins in neurodegenerative diseases

Journal of Biological Chemistry

Volumn 287, Issue 40, 2012, Pages 33109-33115

  Walker, Lary C ^a   LeVine III, Harry ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR UPTAKE; MISFOLDING; PATHOGENIC PROTEINS; THERAPEUTIC STRATEGY;

NEURODEGENERATIVE DISEASES;

PROTEINS;

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; HUNTINGTIN; PRION PROTEIN; TAR DNA BINDING PROTEIN; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIOACCUMULATION; CRYSTALLIZATION; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE PREDISPOSITION; HUMAN; HUNTINGTON CHOREA; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN LOCALIZATION; REVIEW; STRUCTURE ANALYSIS; TAUOPATHY;

AGING; AMYLOIDOGENIC PROTEINS; ANIMALS; BRAIN; HIPPOCAMPUS; HUMANS; HUNTINGTON DISEASE; LEWY BODY DISEASE; MICE; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PRIONS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 84866893801     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R112.399378     Document Type: Review

References (100)

1. Walker, L. C., and LeVine, H. (2000) The cerebral proteopathies: neurodegenerative disorders of protein conformation and assembly. Mol. Neurobiol. 21, 83-95 (Pubitemid 32289470)
2. Balch, W. E., Morimoto, R. I., Dillin, A., and Kelly, J. W. (2008) Adapting proteostasis for disease intervention. Science 319, 916-919 (Pubitemid 351263754)
3. Ben-Zvi, A., Miller, E. A., and Morimoto, R. I. (2009) Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc. Natl. Acad. Sci. U.S.A. 106, 14914-14919
4. Morawe, T., Hiebel, C., Kern, A., and Behl, C. (2012) Protein homeostasis, aging, and Alzheimer disease. Mol. Neurobiol. 10.1007/s12035-012- 8246-0
5. Dunker, A. K., Silman, I., Uversky, V. N., and Sussman, J. L. (2008) Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 18, 756-764
6. Westermark, P., Benson, M. D., Buxbaum, J. N., Cohen, A. S., Frangione, B., Ikeda, S., Masters, C. L., Merlini, G., Saraiva, M. J., and Sipe, J. D. (2007) A primer of amyloid nomenclature. Amyloid 14, 179-183 (Pubitemid 47262691)
7. Sipe, J. D., Benson, M. D., Buxbaum, J. N., Ikeda, S., Merlini, G., Saraiva, M. J., and Westermark, P. (2010) Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 17, 101-104
8. Lee, V. M., Goedert, M., and Trojanowski, J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. of Neurosci. 24, 1121-1159 (Pubitemid 32695256)
9. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies fromParkinson disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95, 6469-6473 (Pubitemid 28249037)
10. Askanas, V., and Engel, W. K. (2006) Inclusion body myositis: a myodegenerative conformational disorder associated with Aβ, protein misfolding, and proteasome inhibition. Neurology 66, S39-S48 (Pubitemid 43739983)
11. Ince, P. G., Highley, J. R., Kirby, J., Wharton, S. B., Takahashi, H., Strong, M. J., and Shaw, P. J. (2011) Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol. 122, 657-671
12. LeVine, H., 3rd, and Walker, L. C. (2010) Molecular polymorphism of Aßin Alzheimer disease. Neurobiol. Aging 31, 542-548
13. Fändrich, M. (2012) Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity. J. Mol. Biol. 421, 427-440
14. Selkoe, D. J. (2011) Resolving controversies on the path to Alzheimer therapeutics. Nat. Med. 17, 1060-1065
15. Westermark, G. T., and Westermark, P. (2010) Prion-like aggregates: infectious agents in human disease. Trends Mol. Med. 16, 501-507
16. Catalano, S. M., Dodson, E. C., Henze, D. A., Joyce, J. G., Krafft, G. A., and Kinney, G. G. (2006) The role of amyloid-β-derived diffusible ligands (ADDLs) in Alzheimer disease. Curr. Top. Med. Chem. 6, 597-608
17. Caughey, B., Baron, G. S., Chesebro, B., and Jeffrey, M. (2009) Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu. Rev. Biochem. 78, 177-204
18. Jucker, M., and Walker, L. C. (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann. Neurol. 70, 532-540
19. Soto, C., Estrada, L., and Castilla, J. (2006) Amyloids, prions, and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci. 31, 150-155 (Pubitemid 43357995)
20. Walker, L. C., and LeVine, H., 3rd. (2000) The cerebral proteopathies. Neurobiol. Aging 21, 559-561 (Pubitemid 30621495)
21. Walker, L. C., LeVine, H., 3rd, Mattson, M. P., and Jucker, M. (2006) Inducible proteopathies. Trends Neurosci. 29, 438-443 (Pubitemid 44118445)
22. Lansbury, P. T., Jr. (1997) Structural neurology: are seeds at the root of neuronal degeneration? Neuron 19, 1151-1154
23. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363-13383
24. Aguzzi, A., and Rajendran, L. (2009) The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64, 783-790
25. Head, M. W., and Ironside, J. W. (2012) Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype, and agent strain. Neuropathol. Appl. Neurobiol. 38, 296-310
26. Aguzzi, A., Heikenwalder, M., and Polymenidou, M. (2007) Insights into prion strains and neurotoxicity. Nat. Rev. Mol. Cell Biol. 8, 552-561 (Pubitemid 46985384)
27. Soto, C. (2011) Prion hypothesis: the end of the controversy? Trends Biochem. Sci. 36, 151-158
28. Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., Jucker, M., Goedert, M., and Tolnay, M. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913
29. Eisele, Y. S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L. H., Yan, Z. X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., and Jucker, M. (2009) Induction of cerebral β-amyloidosis: intracerebral versus systemic Aβ inoculation. Proc. Natl. Acad. Sci. U.S.A. 106, 12926-12931
30. Kane, M. D., Lipinski, W. J., Callahan, M. J., Bian, F., Durham, R. A., Schwarz, R. D., Roher, A. E., and Walker, L. C. (2000) Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts inβ-amyloid precursor protein transgenic mice. J. Neurosci. 20, 3606-3611 (Pubitemid 30266223)
31. Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L., Vigouret, J. M., Paganetti, P., Walsh, D. M., Mathews, P. M., Ghiso, J., Staufenbiel, M., Walker, L. C., and Jucker, M. (2006) Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host.Science 313, 1781-1784 (Pubitemid 44454153)
32. Ren, P. H., Lauckner, J. E., Kachirskaia, I., Heuser, J. E., Melki, R., and Kopito, R. R. (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol. 11, 219-225
33. Brundin, P., Melki, R., and Kopito, R. (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol. 11, 301-307
34. Eisenberg, D., and Jucker, M. (2012) The amyloid state of proteins in human diseases. Cell 148, 1188-1203
35. Goedert, M., Clavaguera, F., and Tolnay, M. (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 33, 317-325
36. Lee, S. J., Desplats, P., Sigurdson, C., Tsigelny, I., and Masliah, E. (2010) Cell-to-cell transmission of non-prion protein aggregates. Nat. Rev. Neurol. 6, 702-706
37. Lundmark, K., Westermark, G. T., Nyström, S., Murphy, C. L., Solomon, A., and Westermark, P. (2002) Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. U.S.A. 99, 6979-6984 (Pubitemid 34526243)
38. Münch, C., and Bertolotti, A. (2012) Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants. J. Mol. Biol. 399, 512-525
39. Polymenidou, M., and Cleveland, D. W. (2012) Prion-like spread of protein aggregates in neurodegeneration. J. Exp. Med. 209, 889-893
40. Jucker, M. (2010) The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat. Med. 16, 1210-1214
41. Heuer, E., Rosen, R. F., Cintron, A., and Walker, L. C. (2012) Non-human primate models of Alzheimer-like cerebral proteopathy. Curr. Pharm. Des. 18, 1159-1169
42. Baker, H. F., Ridley, R. M., Duchen, L. W., Crow, T. J., and Bruton, C. J. (1993) Evidence for the experimental transmission of cerebral β-amyloidosisto primates. Int. J. Exp. Pathol. 74, 441-454 (Pubitemid 23304080)
43. Eisele, Y. S., Obermüller, U., Heilbronner, G., Baumann, F., Kaeser, S. A., Wolburg, H., Walker, L. C., Staufenbiel, M., Heikenwalder, M., and Jucker, M. (2010) Peripherally applied Aβ-containing inoculates induce cerebral β-amyloidosis. Science 330, 980-982
44. Hamaguchi, T., Eisele, Y. S., Varvel, N. H., Lamb, B. T., Walker, L. C., and Jucker, M. (2012) The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain. Acta Neuropathol. 123, 31-37
45. Langer, F., Eisele, Y. S., Fritschi, S. K., Staufenbiel, M., Walker, L. C., and Jucker, M. (2011) Soluble Aβ seeds are potent inducers of cerebral β-amyloiddeposition. J. Neurosci. 31, 14488-14495
46. Morales, R., Duran-Aniotz, C., Castilla, J., Estrada, L. D., and Soto, C. (2012) De novo induction of amyloid-β deposition in vivo. Mol. Psychiatry 10.1038/mp.2011.120
47. Rosen, R. F., Fritz, J. J., Dooyema, J., Cintron, A. F., Hamaguchi, T., Lah, J. J., LeVine, H., 3rd, Jucker, M., and Walker, L. C. (2012) Exogenous seeding of cerebral β-amyloid deposition in βAPP transgenic rats. J. Neurochem. 120, 660-666
48. Watts, J. C., Giles, K., Grillo, S. K., Lemus, A., DeArmond, S. J., and Prusiner, S. B. (2011) Bioluminescence imaging of Aβ deposition in bigenic mouse models of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 108, 2528-2533
49. Stöhr, J., Watts, J. C., Mensinger, Z. L., Oehler, A., Grillo, S. K., Dearmond, S. J., Prusiner, S. B., and Giles, K. (2012) Purified and synthetic Alzheimer amyloid-β (Aβ) prions. Proc. Natl. Acad. Sci. U.S.A. 109, 11025-11030
50. Sc molecules with different conformations. Nat. Med. 4, 1157-1165
51. Münch, C., O'Brien, J., and Bertolotti, A. (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. U.S.A. 108, 3548-3553
52. Raj, A., Kuceyeski, A., and Weiner, M. (2012) A network diffusion model of disease progression in dementia. Neuron 73, 1204-1215
53. Zhou, J., Gennatas, E. D., Kramer, J. H., Miller, B. L., and Seeley, W. W. (2012) Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron 73, 1216-1227
54. Braak, H., and Del Tredici, K. (2011) Alzheimer pathogenesis: is there neuron-to-neuron propagation? Acta Neuropathol. 121, 589-595
55. Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., and Powell, T. P. (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 82, 4531-4534 (Pubitemid 15233154)
56. Saper, C. B., Wainer, B. H., and German, D. C. (1987) Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer disease. Neuroscience 23, 389-398 (Pubitemid 18004218)
57. Thal, D. R., Capetillo-Zarate, E., Del Tredici, K., and Braak, H. (2006) The development of amyloid-β protein deposits in the aged brain. SAGE KE 2006, re1
58. Doty, R. L. (2008) The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann. Neurol. 63, 7-15
59. Kanouchi, T., Ohkubo, T., and Yokota, T. (2012) Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prionlike propagation? J. Neurol. Neurosurg. Psychiatry 83, 739-745
60. Ravits, J. M., and La Spada, A. R. (2009) ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73, 805-811
61. Eidelberg, D., and Surmeier, D. J. (2011) Brain networks in Huntington disease. J. Clin. Invest. 121, 484-492
62. Salinas, S., Schiavo, G., and Kremer, E. J. (2010) A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat. Rev. Microbiol. 8, 645-655
63. Buyukmihci, N., Goehring-Harmon, F., and Marsh, R. F. (1983) Neural pathogenesis of experimental scrapie after intraocular inoculation of hamsters. Exp. Neurol. 81, 396-406 (Pubitemid 13033621)
64. Liberski, P. P., Yanagihara, R., Gibbs, C. J., Jr., and Gajdusek, D. C. (1990) Spread of Creutzfeldt-Jakob disease virus along visual pathways after intraocular inoculation. Arch. Virol. 111, 141-147 (Pubitemid 20323478)
65. Walker, L. C., Callahan, M. J., Bian, F., Durham, R. A., Roher, A. E., and Lipinski, W. J. (2002) Exogenous induction of cerebral β-amyloidosis inßAPP transgenic mice. Peptides 23, 1241-1247 (Pubitemid 34786703)
66. Harris, J. A., Devidze, N., Verret, L., Ho, K., Halabisky, B., Thwin, M. T., Kim, D., Hamto, P., Lo, I., Yu, G. Q., Palop, J. J., Masliah, E., and Mucke, L. (2010) Trans-synaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 68, 428-441
67. Rönnbäck, A., Sagelius, H., Bergstedt, K. D., Näslund, J., Westermark, G. T., Winblad, B., and Graff, C. (2012) Amyloid neuropathology in the single Arctic APP transgenic model affects interconnected brain regions. Neurobiol. Aging 33, 831.e11-9
68. Guo, J. L., and Lee, V. M. (2011) Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J. Biol. Chem. 286, 15317-15331
69. de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., Spires-Jones, T. L., and Hyman, B. T. (2012) Propagation of tau pathology in a model of early Alzheimer disease. Neuron 73, 685-697
70. Liu, L., Drouet, V., Wu, J. W., Witter, M. P., Small, S. A., Clelland, C., and Duff, K. (2012) Trans-synaptic spread of tau pathology in vivo. PloS ONE 7, e31302
71. Cushman, M., Johnson, B. S., King, O. D., Gitler, A. D., and Shorter, J. (2010) Prion-like disorders: blurring the divide between transmissibility and infectivity. J. Cell Sci. 123, 1191-1201
72. Frost, B., and Diamond, M. I. (2009) The expanding realm of prion phenomena in neurodegenerative disease. Prion 3, 74-77
73. Braak, H., Del Tredici, K., Rüb, U., de Vos, R. A., Jansen Steur, E. N., and Braak, E. (2003) Staging of brain pathology related to sporadic Parkinson disease. Neurobiol. Aging 24, 197-211 (Pubitemid 36007810)
74. Alafuzoff, I., Ince, P. G., Arzberger, T., Al-Sarraj, S., Bell, J., Bodi, I., Bogdanovic, N., Bugiani, O., Ferrer, I., Gelpi, E., Gentleman, S., Giaccone, G., Ironside, J. W., Kavantzas, N., King, A., Korkolopoulou, P., Kovács, G. G., Meyronet, D., Monoranu, C., Parchi, P., Parkkinen, L., Patsouris, E., Roggendorf, W., Rozemuller, A., Stadelmann-Nessler, C., Streichenberger, N., Thal, D. R., and Kretzschmar, H. (2009) Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet EuropeConsortium. Acta Neuropathol. 117, 635-652
75. Hawkes, C. H., Del Tredici, K., and Braak, H. (2007) Parkinson disease: a dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 33, 599-614
76. Lee, H. J., Suk, J. E., Lee, K. W., Park, S. H., Blumbergs, P. C., Gai, W. P., and Lee, S. J. (2011) Transmission of synucleinopathies in the enteric nervous system of A53T α-synuclein transgenic mice. Exp. Neurobiol. 20, 181-188
77. Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., and Olanow, C. W. (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson disease. Nat. Med. 14, 504-506 (Pubitemid 351655212)
78. Li, J. Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., Widner, H., Revesz, T., Lindvall, O., and Brundin, P. (2008) Lewy bodies in grafted neurons in subjects with Parkinson disease suggest host-to-graft disease propagation. Nat. Med. 14, 501-503 (Pubitemid 351655211)
79. Hansen, C., Angot, E., Bergström, A. L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., Li, J. Y., and Brundin, P. (2011) α-Synuclein propagates from mouse brain to grafted dopaminergicneurons and seeds aggregation in cultured human cells. J. Clin. Invest. 121, 715-725
80. Kordower, J. H., Dodiya, H. B., Kordower, A. M., Terpstra, B., Paumier, K., Madhavan, L., Sortwell, C., Steece-Collier, K., and Collier, T. J. (2011) Transfer of host-derived α-synuclein to grafted dopaminergic neurons inrat. Neurobiol. Dis. 43, 552-557
81. Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., and Lee, V. M. (2011) Exogenous α-synuclein fibrils induce Lewy body pathology leading tosynaptic dysfunction and neuron death. Neuron 72, 57-71
82. Desplats, P., Lee, H. J., Bae, E. J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., and Lee, S. J. (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein.Proc. Natl. Acad. Sci. U.S.A. 106, 13010-13015
83. Mougenot, A. L., Nicot, S., Bencsik, A., Morignat, E., Verchère, J., Lakhdar, L., Legastelois, S., and Baron, T. (2012) Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 33, 2225-2228
84. Luk, K. C., Kehm, V. M., Zhang, B., O'Brien, P., Trojanowski, J. Q., and Lee, V. M. (2012) Intracerebral inoculation of pathological α- synucleininitiates a rapidly progressive neurodegenerative α- synucleinopathy inmice. J. Exp. Med. 209, 975-986
85. Lagier-Tourenne, C., and Cleveland, D. W. (2009) Rethinking ALS: the FUS about TDP-43. Cell 136, 1001-1004
86. G93A mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PloS ONE 5, e10627
87. Grad, L. I., Guest, W. C., Yanai, A., Pokrishevsky, E., O'Neill, M. A., Gibbs, E., Semenchenko, V., Yousefi, M., Wishart, D. S., Plotkin, S. S., and Cashman, N. R. (2011) Intermolecular transmission of superoxide dismutase-1 misfolding in living cells. Proc. Natl. Acad. Sci. U.S.A. 108, 16398-16403
88. Furukawa, Y., Kaneko, K., Watanabe, S., Yamanaka, K., and Nukina, N. (2011) A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J. Biol. Chem. 286, 18664-18672
89. King, O. D., Gitler, A. D., and Shorter, J. (2012) The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 1462, 61-80
90. Arrasate, M., and Finkbeiner, S. (2011) Protein aggregates in Huntington disease. Exp. Neurol., in press
91. Orr, H. T. (2012) Cell biology of spinocerebellar ataxia. J. Cell Biol. 197, 167-177
92. Frost, B., Jacks, R. L., and Diamond, M. I. (2009) Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845-12852
93. Gousset, K., Schiff, E., Langevin, C., Marijanovic, Z., Caputo, A., Browman, D. T., Chenouard, N., de Chaumont, F., Martino, A., Enninga, J., Olivo-Marin, J. C., Männel, D., and Zurzolo, C. (2009) Prions hijack tunneling nanotubes for intercellular spread. Nat. Cell Biol. 11, 328-336
94. Hu, X., Crick, S. L., Bu, G., Frieden, C., Pappu, R. V., and Lee, J. M. (2009) Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-β peptide. Proc. Natl. Acad. Sci. U.S.A. 106, 20324-20329
95. Kfoury, N., Holmes, B. B., Jiang, H., Holtzman, D. M., and Diamond, M. I. (2012) Transcellular propagation of tau aggregation by fibrillar species. J. Biol. Chem. 287, 19440-19451
96. Paquet, S., Langevin, C., Chapuis, J., Jackson, G. S., Laude, H., and Vilette, D. (2007) Efficient dissemination of prions through preferential transmission to nearby cells. J. Gen. Virol. 88, 706-713 (Pubitemid 46210911)
97. Schneider, A., and Simons, M. (2012) Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Res. 10.1007/s00441-012-1428-2
98. Yang, W., Dunlap, J. R., Andrews, R. B., and Wetzel, R. (2002) Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 11, 2905-2917
99. Nath, S., Agholme, L., Kurudenkandy, F. R., Granseth, B., Marcusson, J., and Hallbeck, M. (2012) Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β-amyloid. J. Neurosci. 32, 8767-8777
100. Hofmann, J., Wolf, H., Grassmann, A., Arndt, V., Graham, J., and Vorberg, I. (2012) Creutzfeldt-Jakob disease and mad cows: lessons learnt from yeast cells. Swiss Med. Wkly. 142, w13505